• +1 513 549 5911 (U.S.)
  • +44 203 318 2846 (U.K.)

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports

In-Vitro Toxicology and Toxicity Testing Market

Covid-19 Impact on Global In-Vitro Toxicology and Toxicity Testing Market Size, Status and Forecast 2020-2026


Covid-19

COVID-19

Understand the influence of COVID-19 on the In-Vitro Toxicology and Toxicity Testing Market with our analysts monitoring the situation across the globe.
In-Vitro Toxicology and Toxicity Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global In-Vitro Toxicology and Toxicity Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the In-Vitro Toxicology and Toxicity Testing market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the In-Vitro Toxicology and Toxicity Testing industry.

The key players covered in this study
    GE Healthcare
    Thermo Fisher Scientific
    Bio-Rad Laboratories
    Agilent Technologies
    Cyprotex
    Covance
    Bioreliance
    Catalent
    Charles River Laboratories International
    Alere
    Eurofins Scientific
    Life Technologies Corporation
    Quest Diagnostics

Market segment by Type, the product can be split into
    Cell Culture Technology
    High Throughput Technologies
    Molecular Imaging Technologies
    Omics Technologies
Market segment by Application, split into
    Pharmaceutical Industry
    Chemical Industry
    Food Industry
    Other

Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

The study objectives of this report are:
    To analyze global In-Vitro Toxicology and Toxicity Testing status, future forecast, growth opportunity, key market and key players.
    To present the In-Vitro Toxicology and Toxicity Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of In-Vitro Toxicology and Toxicity Testing are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.	
1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered: Ranking by In-Vitro Toxicology and Toxicity Testing Revenue
    1.4 Covid-19 Implications on Market by Type
        1.4.1 Global In-Vitro Toxicology and Toxicity Testing Market Size Growth Rate by Type: 2020 VS 2026
        1.4.2 Cell Culture Technology
        1.4.3 High Throughput Technologies
        1.4.4 Molecular Imaging Technologies
        1.4.5 Omics Technologies
    1.5 Market by Application
        1.5.1 Global In-Vitro Toxicology and Toxicity Testing Market Share by Application: 2020 VS 2026
        1.5.2 Pharmaceutical Industry
        1.5.3 Chemical Industry
        1.5.4 Food Industry
        1.5.5 Other
    1.6 Coronavirus Disease 2019 (Covid-19): In-Vitro Toxicology and Toxicity Testing Industry Impact
        1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
        1.6.2 Covid-19 Impact: Commodity Prices Indices
        1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered

2 Global Growth Trends
    2.1 Covid-19 Implications on Global In-Vitro Toxicology and Toxicity Testing Market Perspective (2015-2026)
    2.2 Covid-19 Implications on Global In-Vitro Toxicology and Toxicity Testing Growth Trends by Regions
        2.2.1 In-Vitro Toxicology and Toxicity Testing Market Size by Regions: 2015 VS 2020 VS 2026
        2.2.2 In-Vitro Toxicology and Toxicity Testing Historic Market Share by Regions (2015-2020)
        2.2.3 In-Vitro Toxicology and Toxicity Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
        2.3.3 Market Challenges
        2.3.4 Porter’s Five Forces Analysis
        2.3.5 In-Vitro Toxicology and Toxicity Testing Market Growth Strategy
        2.3.6 Primary Interviews with Key In-Vitro Toxicology and Toxicity Testing Players (Opinion Leaders)

3 Covid-19 Implications on Competition Landscape by Key Players
    3.1 Global Top In-Vitro Toxicology and Toxicity Testing Players by Market Size
        3.1.1 Global Top In-Vitro Toxicology and Toxicity Testing Players by Revenue (2015-2020)
        3.1.2 Global In-Vitro Toxicology and Toxicity Testing Revenue Market Share by Players (2015-2020)
        3.1.3 Global In-Vitro Toxicology and Toxicity Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.2 Global In-Vitro Toxicology and Toxicity Testing Market Concentration Ratio
        3.2.1 Global In-Vitro Toxicology and Toxicity Testing Market Concentration Ratio (CR5 and HHI)
        3.2.2 Global Top 10 and Top 5 Companies by In-Vitro Toxicology and Toxicity Testing Revenue in 2019
    3.3 In-Vitro Toxicology and Toxicity Testing Key Players Head office and Area Served
    3.4 Key Players In-Vitro Toxicology and Toxicity Testing Product Solution and Service
    3.5 Date of Enter into In-Vitro Toxicology and Toxicity Testing Market
    3.6 Mergers & Acquisitions, Expansion Plans

4 Covid-19 Implications on Market Size by Type (2015-2026)
    4.1 Global In-Vitro Toxicology and Toxicity Testing Historic Market Size by Type (2015-2020)
    4.2 Global In-Vitro Toxicology and Toxicity Testing Forecasted Market Size by Type (2021-2026)

5 Covid-19 Implications on Market Size by Application (2015-2026)
    5.1 Global In-Vitro Toxicology and Toxicity Testing Market Size by Application (2015-2020)
    5.2 Global In-Vitro Toxicology and Toxicity Testing Forecasted Market Size by Application (2021-2026)

6 North America Impact of COVID-19
    6.1 North America In-Vitro Toxicology and Toxicity Testing Market Size (2015-2020)
    6.2 In-Vitro Toxicology and Toxicity Testing Key Players in North America (2019-2020)
    6.3 North America In-Vitro Toxicology and Toxicity Testing Market Size by Type (2015-2020)
    6.4 North America In-Vitro Toxicology and Toxicity Testing Market Size by Application (2015-2020)

7 Europe Impact of COVID-19
    7.1 Europe In-Vitro Toxicology and Toxicity Testing Market Size (2015-2020)
    7.2 In-Vitro Toxicology and Toxicity Testing Key Players in Europe (2019-2020)
    7.3 Europe In-Vitro Toxicology and Toxicity Testing Market Size by Type (2015-2020)
    7.4 Europe In-Vitro Toxicology and Toxicity Testing Market Size by Application (2015-2020)

8 China Impact of COVID-19
    8.1 China In-Vitro Toxicology and Toxicity Testing Market Size (2015-2020)
    8.2 In-Vitro Toxicology and Toxicity Testing Key Players in China (2019-2020)
    8.3 China In-Vitro Toxicology and Toxicity Testing Market Size by Type (2015-2020)
    8.4 China In-Vitro Toxicology and Toxicity Testing Market Size by Application (2015-2020)

9 Japan Impact of COVID-19
    9.1 Japan In-Vitro Toxicology and Toxicity Testing Market Size (2015-2020)
    9.2 In-Vitro Toxicology and Toxicity Testing Key Players in Japan (2019-2020)
    9.3 Japan In-Vitro Toxicology and Toxicity Testing Market Size by Type (2015-2020)
    9.4 Japan In-Vitro Toxicology and Toxicity Testing Market Size by Application (2015-2020)

10 Southeast Asia Impact of COVID-19
    10.1 Southeast Asia In-Vitro Toxicology and Toxicity Testing Market Size (2015-2020)
    10.2 In-Vitro Toxicology and Toxicity Testing Key Players in Southeast Asia (2019-2020)
    10.3 Southeast Asia In-Vitro Toxicology and Toxicity Testing Market Size by Type (2015-2020)
    10.4 Southeast Asia In-Vitro Toxicology and Toxicity Testing Market Size by Application (2015-2020)

11 India Impact of COVID-19
    11.1 India In-Vitro Toxicology and Toxicity Testing Market Size (2015-2020)
    11.2 In-Vitro Toxicology and Toxicity Testing Key Players in India (2019-2020)
    11.3 India In-Vitro Toxicology and Toxicity Testing Market Size by Type (2015-2020)
    11.4 India In-Vitro Toxicology and Toxicity Testing Market Size by Application (2015-2020)

12 Central & South America Impact of COVID-19
    12.1 Central & South America In-Vitro Toxicology and Toxicity Testing Market Size (2015-2020)
    12.2 In-Vitro Toxicology and Toxicity Testing Key Players in Central & South America (2019-2020)
    12.3 Central & South America In-Vitro Toxicology and Toxicity Testing Market Size by Type (2015-2020)
    12.4 Central & South America In-Vitro Toxicology and Toxicity Testing Market Size by Application (2015-2020)

13Key Players Profiles
    13.1 GE Healthcare
        13.1.1 GE Healthcare Company Details
        13.1.2 GE Healthcare Business Overview and Its Total Revenue
        13.1.3 GE Healthcare In-Vitro Toxicology and Toxicity Testing Introduction
        13.1.4 GE Healthcare Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020))
        13.1.5 GE Healthcare Recent Development and Reaction to COVID-19
    13.2 Thermo Fisher Scientific
        13.2.1 Thermo Fisher Scientific Company Details
        13.2.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
        13.2.3 Thermo Fisher Scientific In-Vitro Toxicology and Toxicity Testing Introduction
        13.2.4 Thermo Fisher Scientific Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
        13.2.5 Thermo Fisher Scientific Recent Development and Reaction to COVID-19
    13.3 Bio-Rad Laboratories
        13.3.1 Bio-Rad Laboratories Company Details
        13.3.2 Bio-Rad Laboratories Business Overview and Its Total Revenue
        13.3.3 Bio-Rad Laboratories In-Vitro Toxicology and Toxicity Testing Introduction
        13.3.4 Bio-Rad Laboratories Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
        13.3.5 Bio-Rad Laboratories Recent Development and Reaction to COVID-19
    13.4 Agilent Technologies
        13.4.1 Agilent Technologies Company Details
        13.4.2 Agilent Technologies Business Overview and Its Total Revenue
        13.4.3 Agilent Technologies In-Vitro Toxicology and Toxicity Testing Introduction
        13.4.4 Agilent Technologies Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
        13.4.5 Agilent Technologies Recent Development and Reaction to COVID-19
    13.5 Cyprotex
        13.5.1 Cyprotex Company Details
        13.5.2 Cyprotex Business Overview and Its Total Revenue
        13.5.3 Cyprotex In-Vitro Toxicology and Toxicity Testing Introduction
        13.5.4 Cyprotex Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
        13.5.5 Cyprotex Recent Development and Reaction to COVID-19
    13.6 Covance
        13.6.1 Covance Company Details
        13.6.2 Covance Business Overview and Its Total Revenue
        13.6.3 Covance In-Vitro Toxicology and Toxicity Testing Introduction
        13.6.4 Covance Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
        13.6.5 Covance Recent Development and Reaction to COVID-19
    13.7 Bioreliance
        13.7.1 Bioreliance Company Details
        13.7.2 Bioreliance Business Overview and Its Total Revenue
        13.7.3 Bioreliance In-Vitro Toxicology and Toxicity Testing Introduction
        13.7.4 Bioreliance Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
        13.7.5 Bioreliance Recent Development and Reaction to COVID-19
    13.8 Catalent
        13.8.1 Catalent Company Details
        13.8.2 Catalent Business Overview and Its Total Revenue
        13.8.3 Catalent In-Vitro Toxicology and Toxicity Testing Introduction
        13.8.4 Catalent Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
        13.8.5 Catalent Recent Development and Reaction to COVID-19
    13.9 Charles River Laboratories International
        13.9.1 Charles River Laboratories International Company Details
        13.9.2 Charles River Laboratories International Business Overview and Its Total Revenue
        13.9.3 Charles River Laboratories International In-Vitro Toxicology and Toxicity Testing Introduction
        13.9.4 Charles River Laboratories International Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
        13.9.5 Charles River Laboratories International Recent Development and Reaction to COVID-19
    13.10 Alere
        13.10.1 Alere Company Details
        13.10.2 Alere Business Overview and Its Total Revenue
        13.10.3 Alere In-Vitro Toxicology and Toxicity Testing Introduction
        13.10.4 Alere Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
        13.10.5 Alere Recent Development and Reaction to COVID-19
    13.11 Eurofins Scientific
        10.11.1 Eurofins Scientific Company Details
        10.11.2 Eurofins Scientific Business Overview and Its Total Revenue
        10.11.3 Eurofins Scientific In-Vitro Toxicology and Toxicity Testing Introduction
        10.11.4 Eurofins Scientific Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
        10.11.5 Eurofins Scientific Recent Development and Reaction to COVID-19
    13.12 Life Technologies Corporation
        10.12.1 Life Technologies Corporation Company Details
        10.12.2 Life Technologies Corporation Business Overview and Its Total Revenue
        10.12.3 Life Technologies Corporation In-Vitro Toxicology and Toxicity Testing Introduction
        10.12.4 Life Technologies Corporation Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
        10.12.5 Life Technologies Corporation Recent Development and Reaction to COVID-19
    13.13 Quest Diagnostics
        10.13.1 Quest Diagnostics Company Details
        10.13.2 Quest Diagnostics Business Overview and Its Total Revenue
        10.13.3 Quest Diagnostics In-Vitro Toxicology and Toxicity Testing Introduction
        10.13.4 Quest Diagnostics Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
        10.13.5 Quest Diagnostics Recent Development and Reaction to COVID-19

14Analyst's Viewpoints/Conclusions

15Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Disclaimer
    15.3 Author Details

	List of Tables
    Table 1. In-Vitro Toxicology and Toxicity Testing Key Market Segments
    Table 2. Key Players Covered: Ranking by In-Vitro Toxicology and Toxicity Testing Revenue
    Table 3. Ranking of Global Top In-Vitro Toxicology and Toxicity Testing Manufacturers by Revenue (US$ Million) in 2019
    Table 4. Global In-Vitro Toxicology and Toxicity Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
    Table 5. Key Players of Cell Culture Technology
    Table 6. Key Players of High Throughput Technologies
    Table 7. Key Players of Molecular Imaging Technologies
    Table 8. Key Players of Omics Technologies
    Table 9. COVID-19 Impact Global Market: (Four In-Vitro Toxicology and Toxicity Testing Market Size Forecast Scenarios)
    Table 10. Opportunities and Trends for In-Vitro Toxicology and Toxicity Testing Players in the COVID-19 Landscape
    Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
    Table 12. Key Regions/Countries Measures against Covid-19 Impact
    Table 13. Proposal for In-Vitro Toxicology and Toxicity Testing Players to Combat Covid-19 Impact
    Table 14. Global In-Vitro Toxicology and Toxicity Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
    Table 15. Global In-Vitro Toxicology and Toxicity Testing Market Size by Regions (US$ Million): 2020 VS 2026
    Table 16. Global In-Vitro Toxicology and Toxicity Testing Market Size by Regions (2015-2020) (US$ Million)
    Table 17. Global In-Vitro Toxicology and Toxicity Testing Market Share by Regions (2015-2020)
    Table 18. Global In-Vitro Toxicology and Toxicity Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
    Table 19. Global In-Vitro Toxicology and Toxicity Testing Market Share by Regions (2021-2026)
    Table 20. Market Top Trends
    Table 21. Key Drivers: Impact Analysis
    Table 22. Key Challenges
    Table 23. In-Vitro Toxicology and Toxicity Testing Market Growth Strategy
    Table 24. Main Points Interviewed from Key In-Vitro Toxicology and Toxicity Testing Players
    Table 25. Global In-Vitro Toxicology and Toxicity Testing Revenue by Players (2015-2020) (Million US$)
    Table 26. Global In-Vitro Toxicology and Toxicity Testing Market Share by Players (2015-2020)
    Table 27. Global Top In-Vitro Toxicology and Toxicity Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in In-Vitro Toxicology and Toxicity Testing as of 2019)
    Table 28. Global In-Vitro Toxicology and Toxicity Testing by Players Market Concentration Ratio (CR5 and HHI)
    Table 29. Key Players Headquarters and Area Served
    Table 30. Key Players In-Vitro Toxicology and Toxicity Testing Product Solution and Service
    Table 31. Date of Enter into In-Vitro Toxicology and Toxicity Testing Market
    Table 32. Mergers & Acquisitions, Expansion Plans
    Table 33. Global In-Vitro Toxicology and Toxicity Testing Market Size by Type (2015-2020) (Million US$)
    Table 34. Global In-Vitro Toxicology and Toxicity Testing Market Size Share by Type (2015-2020)
    Table 35. Global In-Vitro Toxicology and Toxicity Testing Revenue Market Share by Type (2021-2026)
    Table 36. Global In-Vitro Toxicology and Toxicity Testing Market Size Share by Application (2015-2020)
    Table 37. Global In-Vitro Toxicology and Toxicity Testing Market Size by Application (2015-2020) (Million US$)
    Table 38. Global In-Vitro Toxicology and Toxicity Testing Market Size Share by Application (2021-2026)
    Table 39. North America Key Players In-Vitro Toxicology and Toxicity Testing Revenue (2019-2020) (Million US$)
    Table 40. North America Key Players In-Vitro Toxicology and Toxicity Testing Market Share (2019-2020)
    Table 41. North America In-Vitro Toxicology and Toxicity Testing Market Size by Type (2015-2020) (Million US$)
    Table 42. North America In-Vitro Toxicology and Toxicity Testing Market Share by Type (2015-2020)
    Table 43. North America In-Vitro Toxicology and Toxicity Testing Market Size by Application (2015-2020) (Million US$)
    Table 44. North America In-Vitro Toxicology and Toxicity Testing Market Share by Application (2015-2020)
    Table 45. Europe Key Players In-Vitro Toxicology and Toxicity Testing Revenue (2019-2020) (Million US$)
    Table 46. Europe Key Players In-Vitro Toxicology and Toxicity Testing Market Share (2019-2020)
    Table 47. Europe In-Vitro Toxicology and Toxicity Testing Market Size by Type (2015-2020) (Million US$)
    Table 48. Europe In-Vitro Toxicology and Toxicity Testing Market Share by Type (2015-2020)
    Table 49. Europe In-Vitro Toxicology and Toxicity Testing Market Size by Application (2015-2020) (Million US$)
    Table 50. Europe In-Vitro Toxicology and Toxicity Testing Market Share by Application (2015-2020)
    Table 51. China Key Players In-Vitro Toxicology and Toxicity Testing Revenue (2019-2020) (Million US$)
    Table 52. China Key Players In-Vitro Toxicology and Toxicity Testing Market Share (2019-2020)
    Table 53. China In-Vitro Toxicology and Toxicity Testing Market Size by Type (2015-2020) (Million US$)
    Table 54. China In-Vitro Toxicology and Toxicity Testing Market Share by Type (2015-2020)
    Table 55. China In-Vitro Toxicology and Toxicity Testing Market Size by Application (2015-2020) (Million US$)
    Table 56. China In-Vitro Toxicology and Toxicity Testing Market Share by Application (2015-2020)
    Table 57. Japan Key Players In-Vitro Toxicology and Toxicity Testing Revenue (2019-2020) (Million US$)
    Table 58. Japan Key Players In-Vitro Toxicology and Toxicity Testing Market Share (2019-2020)
    Table 59. Japan In-Vitro Toxicology and Toxicity Testing Market Size by Type (2015-2020) (Million US$)
    Table 60. Japan In-Vitro Toxicology and Toxicity Testing Market Share by Type (2015-2020)
    Table 61. Japan In-Vitro Toxicology and Toxicity Testing Market Size by Application (2015-2020) (Million US$)
    Table 62. Japan In-Vitro Toxicology and Toxicity Testing Market Share by Application (2015-2020)
    Table 63. Southeast Asia Key Players In-Vitro Toxicology and Toxicity Testing Revenue (2019-2020) (Million US$)
    Table 64. Southeast Asia Key Players In-Vitro Toxicology and Toxicity Testing Market Share (2019-2020)
    Table 65. Southeast Asia In-Vitro Toxicology and Toxicity Testing Market Size by Type (2015-2020) (Million US$)
    Table 66. Southeast Asia In-Vitro Toxicology and Toxicity Testing Market Share by Type (2015-2020)
    Table 67. Southeast Asia In-Vitro Toxicology and Toxicity Testing Market Size by Application (2015-2020) (Million US$)
    Table 68. Southeast Asia In-Vitro Toxicology and Toxicity Testing Market Share by Application (2015-2020)
    Table 69. India Key Players In-Vitro Toxicology and Toxicity Testing Revenue (2019-2020) (Million US$)
    Table 70. India Key Players In-Vitro Toxicology and Toxicity Testing Market Share (2019-2020)
    Table 71. India In-Vitro Toxicology and Toxicity Testing Market Size by Type (2015-2020) (Million US$)
    Table 72. India In-Vitro Toxicology and Toxicity Testing Market Share by Type (2015-2020)
    Table 73. India In-Vitro Toxicology and Toxicity Testing Market Size by Application (2015-2020) (Million US$)
    Table 74. India In-Vitro Toxicology and Toxicity Testing Market Share by Application (2015-2020)
    Table 75. Central & South America Key Players In-Vitro Toxicology and Toxicity Testing Revenue (2019-2020) (Million US$)
    Table 76. Central & South America Key Players In-Vitro Toxicology and Toxicity Testing Market Share (2019-2020)
    Table 77. Central & South America In-Vitro Toxicology and Toxicity Testing Market Size by Type (2015-2020) (Million US$)
    Table 78. Central & South America In-Vitro Toxicology and Toxicity Testing Market Share by Type (2015-2020)
    Table 79. Central & South America In-Vitro Toxicology and Toxicity Testing Market Size by Application (2015-2020) (Million US$)
    Table 80. Central & South America In-Vitro Toxicology and Toxicity Testing Market Share by Application (2015-2020)
    Table 81. GE Healthcare Company Details
    Table 82. GE Healthcare Business Overview
    Table 83. GE Healthcare Product
    Table 84. GE Healthcare Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020) (Million US$)
    Table 85. GE Healthcare Recent Development
    Table 86. Thermo Fisher Scientific Company Details
    Table 87. Thermo Fisher Scientific Business Overview
    Table 88. Thermo Fisher Scientific Product
    Table 89. Thermo Fisher Scientific Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020) (Million US$)
    Table 90. Thermo Fisher Scientific Recent Development
    Table 91. Bio-Rad Laboratories Company Details
    Table 92. Bio-Rad Laboratories Business Overview
    Table 93. Bio-Rad Laboratories Product
    Table 94. Bio-Rad Laboratories Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020) (Million US$)
    Table 95. Bio-Rad Laboratories Recent Development
    Table 96. Agilent Technologies Company Details
    Table 97. Agilent Technologies Business Overview
    Table 98. Agilent Technologies Product
    Table 99. Agilent Technologies Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020) (Million US$)
    Table 100. Agilent Technologies Recent Development
    Table 101. Cyprotex Company Details
    Table 102. Cyprotex Business Overview
    Table 103. Cyprotex Product
    Table 104. Cyprotex Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020) (Million US$)
    Table 105. Cyprotex Recent Development
    Table 106. Covance Company Details
    Table 107. Covance Business Overview
    Table 108. Covance Product
    Table 109. Covance Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020) (Million US$)
    Table 110. Covance Recent Development
    Table 111. Bioreliance Company Details
    Table 112. Bioreliance Business Overview
    Table 113. Bioreliance Product
    Table 114. Bioreliance Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020) (Million US$)
    Table 115. Bioreliance Recent Development
    Table 116. Catalent Business Overview
    Table 117. Catalent Product
    Table 118. Catalent Company Details
    Table 119. Catalent Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020) (Million US$)
    Table 120. Catalent Recent Development
    Table 121. Charles River Laboratories International Company Details
    Table 122. Charles River Laboratories International Business Overview
    Table 123. Charles River Laboratories International Product
    Table 124. Charles River Laboratories International Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020) (Million US$)
    Table 125. Charles River Laboratories International Recent Development
    Table 126. Alere Company Details
    Table 127. Alere Business Overview
    Table 128. Alere Product
    Table 129. Alere Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020) (Million US$)
    Table 130. Alere Recent Development
    Table 131. Eurofins Scientific Company Details
    Table 132. Eurofins Scientific Business Overview
    Table 133. Eurofins Scientific Product
    Table 134. Eurofins Scientific Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020) (Million US$)
    Table 135. Eurofins Scientific Recent Development
    Table 136. Life Technologies Corporation Company Details
    Table 137. Life Technologies Corporation Business Overview
    Table 138. Life Technologies Corporation Product
    Table 139. Life Technologies Corporation Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020) (Million US$)
    Table 140. Life Technologies Corporation Recent Development
    Table 141. Quest Diagnostics Company Details
    Table 142. Quest Diagnostics Business Overview
    Table 143. Quest Diagnostics Product
    Table 144. Quest Diagnostics Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020) (Million US$)
    Table 145. Quest Diagnostics Recent Development
    Table 146. Research Programs/Design for This Report
    Table 147. Key Data Information from Secondary Sources
    Table 148. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global In-Vitro Toxicology and Toxicity Testing Market Share by Type: 2020 VS 2026
    Figure 2. Cell Culture Technology Features
    Figure 3. High Throughput Technologies Features
    Figure 4. Molecular Imaging Technologies Features
    Figure 5. Omics Technologies Features
    Figure 6. Global In-Vitro Toxicology and Toxicity Testing Market Share by Application: 2020 VS 2026
    Figure 7. Pharmaceutical Industry Case Studies
    Figure 8. Chemical Industry Case Studies
    Figure 9. Food Industry Case Studies
    Figure 10. Other Case Studies
    Figure 11. In-Vitro Toxicology and Toxicity Testing Report Years Considered
    Figure 12. Global In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth 2015-2026 (US$ Million)
    Figure 13. Global In-Vitro Toxicology and Toxicity Testing Market Share by Regions: 2020 VS 2026
    Figure 14. Global In-Vitro Toxicology and Toxicity Testing Market Share by Regions (2021-2026)
    Figure 15. Porter's Five Forces Analysis
    Figure 16. Global In-Vitro Toxicology and Toxicity Testing Market Share by Players in 2019
    Figure 17. Global Top In-Vitro Toxicology and Toxicity Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in In-Vitro Toxicology and Toxicity Testing as of 2019
    Figure 18. The Top 10 and 5 Players Market Share by In-Vitro Toxicology and Toxicity Testing Revenue in 2019
    Figure 19. North America In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2015-2020) (Million US$)
    Figure 20. Europe In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2015-2020) (Million US$)
    Figure 21. China In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2015-2020) (Million US$)
    Figure 22. Japan In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2015-2020) (Million US$)
    Figure 23. Southeast Asia In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2015-2020) (Million US$)
    Figure 24. India In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2015-2020) (Million US$)
    Figure 25. Central & South America In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2015-2020) (Million US$)
    Figure 26. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 27. GE Healthcare Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
    Figure 28. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 29. Thermo Fisher Scientific Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
    Figure 30. Bio-Rad Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 31. Bio-Rad Laboratories Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
    Figure 32. Agilent Technologies Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 33. Agilent Technologies Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
    Figure 34. Cyprotex Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 35. Cyprotex Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
    Figure 36. Covance Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 37. Covance Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
    Figure 38. Bioreliance Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 39. Bioreliance Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
    Figure 40. Catalent Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 41. Catalent Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
    Figure 42. Charles River Laboratories International Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 43. Charles River Laboratories International Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
    Figure 44. Alere Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 45. Alere Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
    Figure 46. Eurofins Scientific Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 47. Eurofins Scientific Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
    Figure 48. Life Technologies Corporation Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 49. Life Technologies Corporation Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
    Figure 50. Quest Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 51. Quest Diagnostics Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
    Figure 54. Key Executives Interviewed

Related Reports

Next-Generation-Sequencing-Market

Global Next Generation Sequencing Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)

The Next Generation Sequencing market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Next Generation Sequencing m ...read more

Electrophysiology-Market

Global Electrophysiology Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)

The Electrophysiology market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Electrophysiology market report is a ...read more

Thickeners-Market

Global Thickeners Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)

The Thickeners market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Thickeners market report is a comprehensive ...read more

Bone-Broth-Protein-Market

Global Bone Broth Protein Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)

The Bone Broth Protein market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Bone Broth Protein market report is ...read more

Cervical-Dysplasia-Market

Global Cervical Dysplasia Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)

The Cervical Dysplasia market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Cervical Dysplasia market report is ...read more

Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.

Cards For Payment
Trusted Badge SSL Certified Premium Quality

Why Choose Us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

How To Reach Us

Reach out to our most senior Sales Professional- Jay Matthews
   +1 513 549 5911 (US)
          +44 203 318 2846 (UK)
   sales@reportsmonitor.com

Our Clients

Samsung 3M BCG LEK Consulting McKinsey Thyssenkrupp Mogensen BASF IQVIA Hella Oracle Accenture Saint Gobain

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
--Marketing Manager at a pharma company in Belgium

Enquire Before Buying

Need to ask a quick question before buying? Please fill out this short form:

Our Features

Wide Network of Publishers

Wide Network of Publishers

Access to over 1M+ market research reports

Trusted by the Best

Trusted by the Best

50+ Clients in Fortune 500

Competitive Pricing

Competitive Pricing

Our regular promotional offers and discounts make us the most economic seller of market reports

Safe and Secure

Safe and Secure

Your payment details are protected by us.